News

Dr. Hoffman and MAS scientists

Real Deliverables in Our Lifetime

Foundation News Research News

“Traditionally, drug development has been left to pharmaceutical companies,” Charlie explains, “and if they didn’t see a profit margin in it, they didn’t explore it; even if it was good science. By contrast, it’s much scarier for those of us in academia to pursue drug development.” Charlie, or more formally, Charles Hoffman PhD, the Director […]

Click to Read